Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Dopamine hypothesis of schizophrenia: making sense of it all.

Toda M, Abi-Dargham A.

Curr Psychiatry Rep. 2007 Aug;9(4):329-36. Review.

PMID:
17880866
2.

Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.

Sanyal S, Van Tol HH.

J Psychiatr Res. 1997 Mar-Apr;31(2):219-32. Review.

PMID:
9278187
3.

Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.

Reynolds GP.

Acta Psychiatr Scand Suppl. 1994;380:36-40. Review.

PMID:
7914046
4.

Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.

Pani L, Pira L, Marchese G.

Eur Psychiatry. 2007 Jul;22(5):267-75. Epub 2007 Apr 6. Review.

PMID:
17419008
5.

[Schizophrenia: a psychobiological view].

Rodríguez-Arias M, Aguilar MA, Espert R, Miñarro J.

Rev Neurol. 1996 Oct;24(134):1210-20. Review. Spanish.

PMID:
8983716
6.

Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.

Di Pietro NC, Seamans JK.

Pharmacopsychiatry. 2007 Dec;40 Suppl 1:S27-33. doi: 10.1055/s-2007-992133. Review.

PMID:
18080940
7.

Neurobiology of dopamine in schizophrenia.

Guillin O, Abi-Dargham A, Laruelle M.

Int Rev Neurobiol. 2007;78:1-39. Review.

PMID:
17349856
8.

[The dopamine hypothesis of schizophrenia. New findings for an old theory].

Heinz A.

Nervenarzt. 2000 Jan;71(1):54-7. Review. German.

PMID:
10695033
9.

Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions.

Schwartz JC, Diaz J, Pilon C, Sokoloff P.

Brain Res Brain Res Rev. 2000 Mar;31(2-3):277-87. Review.

PMID:
10719154
10.

[Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].

Guise S, Soubrouillard C, Blin O.

Encephale. 1997 Apr;23 Spec No 2:10-6. Review. French.

PMID:
9273300
11.

Dopamine receptors and schizophrenia.

Reynolds GP.

Biochem Soc Trans. 1996 Feb;24(1):202-5. Review. No abstract available.

PMID:
8674664
12.

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.

Laruelle M, Kegeles LS, Abi-Dargham A.

Ann N Y Acad Sci. 2003 Nov;1003:138-58. Review.

PMID:
14684442
13.

[The dopaminergic hypothesis revisited].

Guillin O.

Encephale. 2006 Oct;32(5 Pt 4):S908-11; discussion S912. Review. French. No abstract available.

PMID:
17119503
14.

The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.

van Kammen DP.

Psychol Med. 1991 Nov;21(4):881-95. Review.

PMID:
1685791
15.

Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids.

Citver AS, Shields AM, Ciaccia LM, Schulingkamp RJ, Raffa RB.

J Clin Pharm Ther. 2002 Jun;27(3):161-8. Review.

PMID:
12081629
16.

Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.

Guillin O, Demily C, Thibaut F.

Int Rev Neurobiol. 2007;78:377-95. Review.

PMID:
17349867
17.

Schizophrenia.

Freedman R.

N Engl J Med. 2003 Oct 30;349(18):1738-49. Review. No abstract available.

PMID:
14585943
18.

[Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].

Heinz A, Braus DF, Romero B, Gallinat J, Puls I, Juckel G, Weinberger DR.

Nervenarzt. 2004 Sep;75(9):845-56. Review. German.

PMID:
15372159
19.

The dopamine D4 receptor in schizophrenia: an update.

Kerwin RW, Collier D.

Psychol Med. 1996 Mar;26(2):221-7. Review. No abstract available.

PMID:
8685278
20.

Schizophrenia: D4 receptor elevation. What does it mean?

Seeman MV.

J Psychiatry Neurosci. 1994 May;19(3):171-6. Review. No abstract available.

Supplemental Content

Support Center